Temasek Trust’s Catalytic Capital for Climate and Health (C3H) has spearheaded a US$1.2m funding round for Singapore-based AI healthtech company injewelme. The funding, which also saw participation from the UK-based Richardson Family, aims to scale injewelme’s contactless health monitoring technology, DeepHealthVision (DHV), to address climate-related health risks.
Injewelme’s DHV technology utilises remote photoplethysmography (rPPG) to monitor over 20 vital health parameters, such as heart rate and blood pressure, using a standard camera within 30 seconds. The technology, which boasts a 95% accuracy rate in real-world pilots, has been trialled with SingHealth Polyclinics and private sector partners like SJ Group’s SJ Integrated Solutions. It is now being evaluated for broader deployment across healthcare, eldercare, insurance, and workplace safety sectors.
The funds will support further development of DHV, including new capabilities for monitoring blood glucose, stress index, and hydration, whilst accelerating injewelme’s customer acquisition in Singapore and expansion into Southeast Asia. Ryan Tan, Head of C3H, highlighted the importance of the technology in addressing climate-related stressors, stating, “We are pleased to support injewelme in the deployment and further development of their technology to anticipate and address the impact of heat-related stress.”
The Richardson Family expressed their enthusiasm for supporting injewelme, noting the company’s embodiment of innovation and entrepreneurship. Co-Axis, a digital impact marketplace, played a pivotal role in connecting injewelme with C3H and the Richardson Family, aligning with their commitment to scaling innovative solutions at the intersection of climate and health.
